Genflow Biosciences (LON:GENF) Trading Up 21.9% – Time to Buy?

by · The Markets Daily

Genflow Biosciences plc (LON:GENF – Get Free Report)’s stock price was up 21.9% during trading on Monday . The stock traded as high as GBX 2.04 and last traded at GBX 2.04. 17,691,867 shares traded hands during trading, an increase of 678% from the average session volume of 2,273,904 shares. The stock had previously closed at GBX 1.67.

Genflow Biosciences Price Performance

The business’s fifty day moving average price is GBX 2.03 and its two-hundred day moving average price is GBX 2.05. The stock has a market capitalization of £10.20 million, a PE ratio of -5.42 and a beta of 2.30.

About Genflow Biosciences

(Get Free Report)

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.

Read More